The Chief Scientific/Technology Officer of VIVEbiotech, Juan Carlos Ramírez, participates in a symposium on gene therapy at the UAM

Dr. Juan Carlos Ramírez, Chief Scientific/Technology Officer of VIVEbiotech, participated in the informative symposium entitled "Present and Future Vision of Gene Therapy: 360º Approach" last Monday.

In the event sponsored by the Dr. Antoni Esteve Foundation, the Spanish Society of Gene and Cell Therapy, the Autonomous University of Madrid, the Teófilo Hernando Foundation Institute and the TerCel Network (Cellular Therapy Network), Juan Carlos Ramírez gave a talk entitled "Manufacturing of viral vectors for gene therapy: current difficulties and challenges".

In the symposium the speakers talked about in vivo gene therapy, ex vivo gene therapy, their applications, as well as the importance of infrastructures in gene therapy.

For more information about the symposium, click here.

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)